#TCMD

Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025 Tactile Medical (Nasdaq: TCMD) announced it will release third quarter fiscal 2025 financial results after market close on Monday, November 3, 2025. Management will host a conference call with Q&A on November 3, 2025 at 5:00 p.m. ET.Investors can join by phone at 877-407-3088 (international 201-389-0927) using access code 13755883, or listen via live webcast at investors.tactilemedical.com. A replay will be available for two weeks at 877-660-6853 (international 201-612-7415), access code 13755883. The webcast will be archived on the investor site.About the company: Tactile Medical develops at-home therapies for chronic conditions including lymphedema, lipedema, chronic venous insufficiency, and chronic pulmonary disease to expand access and improve patient quality of life.

4 months ago

#TCMD Tactile Medical to Release Third Quarter of Fiscal Year 2025 Financial Results on November 3, 2025

www.stocktitan.net/news/TCMD/tactile-medica...

0 0 0 0

Leading Indicators, Tuesday August 5, 2025 – Crystal Equity Research

7 months ago

Small-cap stocks with strong volume gains, Tue Aug 5th - #XMTR #VANI #ALTI #CSTI #EVGO #LRMO #ORGN #PHLT #RIGL #SNDX #WHLR #TCMD #YALA #VVX #QUAD #PACK #NGVT #MBI #EQV #AMWL - More: crystalequityresearch.com/leading-indi... - #smallcap

0 0 0 0

Nasdaq

@nasdaq.activitypub.awakari.com.ap.brid.gy

7 months ago

Tactile Systems (TCMD) Q2 Revenue Up 8% | The Motley Fool

#TCMD #9cd4721c-ed63-43b3-922b-adf347394677 #data-news

Origin | Interest | Match

0 0 0 0

Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results Tactile Systems Technology (NASDAQ: TCMD) reported Q2 2025 financial results with total revenue increasing 7.8% year-over-year to $78.9 million. The company achieved a gross margin of 75% and net income of $3.2 million, compared to $4.3 million in Q2 2024.Key highlights include a 52% increase in airway clearance product sales and a 2% increase in lymphedema product line revenue. The company completed its $30 million share repurchase program, with $16.5 million repurchased in Q2. Management updated 2025 guidance, now expecting full-year revenue of $310-315 million and adjusted EBITDA of $33-35 million.

7 months ago

#TCMD Tactile Systems Technology, Inc. Reports Second Quarter 2025 Financial Results

www.stocktitan.net/news/TCMD/tactile-system...

0 0 0 0

Tactile Medical Q2 Earnings: Medical Tech Leader Sets Key Financial Update for August 4 Medical tech company's Q2 results coming August 4 after market close, followed by 5PM ET conference call. Get insights into chronic care therapy performance.

7 months ago

#TCMD Tactile Medical to Release Second Quarter of Fiscal Year 2025 Financial Results on August 4, 2025

www.stocktitan.net/news/TCMD/tactile-medica...

0 0 0 0

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

9 months ago

Small-cap stocks with declining money flow, Wed Jun 4th - #SXTP #TCMD #SBGI #POWW #OCG #MBRX #LOOP #KGEI #HIFS #GALT #FHTX #CCRN #BTMD #PCG #HTH - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 0 0

Breakthrough Clinical Trial: New Device Cuts Lymphedema Treatment Time in Half for Cancer Survivors New data from largest head/neck cancer lymphedema trial reveals faster treatment initiation and superior outcomes with Flexitouch Plus. See complete results.

9 months ago

#TCMD New Data Demonstrates Significant Clinical and Quality-of-Life Benefits of Flexitouch® Plus in Treating Lymphedema Among Head and Neck Cancer Survivors

www.stocktitan.net/news/TCMD/new-data-demon...

0 0 0 0

Tactile Medical Earnings Miss: Company Slashes 2025 Outlook Amid Sales Force Restructuring Tactile Medical reports Q1 revenue of $61.3M, revises full-year outlook amid strategic transformation. See how Nimbl expansion impacts growth trajectory.

10 months ago

#TCMD Tactile Systems Technology, Inc. Reports First Quarter 2025 Financial Results

www.stocktitan.net/news/TCMD/tactile-system...

0 0 0 0

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

1 year ago

Small-cap stocks with strong volume declines, Wed Feb 19th - #WOOF #XOS #CHCT #DEC #FVRR #JELD #MBC #UIC #ALZN #BMBL #CMMB #LNKB #NEXN #PERI #SBLK #TCMD #VACH - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 0 0

Tactile Medical Smashes Q4 Targets: Record Revenue Growth and Margin Expansion Signal Strong Momentum Tactile Medical delivers robust Q4 with 10% revenue growth, margin expansion to 75%, and strengthened cash position of $94.4M, setting stage for continued growth

1 year ago

#TCMD Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results

www.stocktitan.net/news/TCMD/tactile-system...

0 0 0 0

SmCpStr Technicals – Technical Indicators for Small-cap Stocks

1 year ago

Small-cap stocks with declining money flow, Thu Feb 6th - #AMS #TCMD #ATSG #PET #BGM #NVAX #CNCK #FTRE - More: crystalequityresearch.com/SmCpStr/ - #smallcap

0 0 0 0

Earnings Alert: Tactile Systems Sets Date for Critical Q4 Financial Report Tactile Systems Technology schedules Q4 and FY2024 earnings release for February 18, with conference call and webcast to discuss at-home therapy business performance.

1 year ago

#TCMD Tactile Medical to Release Fourth Quarter and Fiscal Year 2024 Financial Results on February 18, 2025

www.stocktitan.net/news/TCMD/tactile-medica...

0 0 0 0

Groundbreaking Lymphedema Device Now Available: 68% Lighter, Smart-Connected Treatment Transforms Patient Care Tactile Medical launches enhanced Nimbl compression device nationwide, offering 16M Americans a 68% lighter, Bluetooth-enabled solution for lower extremity lymphedema management.

1 year ago

#TCMD Tactile Medical Expands Launch of Nimbl™ to Include Patients with Lower Extremity Lymphedema

www.stocktitan.net/news/TCMD/tactile-medica...

0 0 0 0

Julio Martagón

@jmastragon.bsky.social

1 year ago

Hoy tocó hacer #TCMD coronarios. #Radiologia
#TSID.

1 0 0 0